{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:32:54Z","timestamp":1759937574982},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126119","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T14:15:27Z","timestamp":1432649727000},"page":"e0126119","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome"],"prefix":"10.1371","volume":"10","author":[{"given":"Vanessa","family":"Hoang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangjiang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheba M.","family":"Mohankumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpita K.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"DA Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"R Azziz","year":"2004","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1358\/dot.2009.45.10.1429463","article-title":"Polycystic ovary syndrome and metabolic comorbidities: therapeutic options","volume":"45","author":"V De Leo","year":"2009","journal-title":"Drugs Today (Barc)"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13697130903003842","article-title":"Cardiovascular risk and events in polycystic ovary syndrome","volume":"12","author":"E Carmina","year":"2009","journal-title":"Climacteric"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"E Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"MA Birdsall","year":"1997","journal-title":"Annals of internal medicine"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"GS Conway","year":"1992","journal-title":"Clinical endocrinology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"AD Coviello","year":"2006","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a019028","article-title":"Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?","volume":"11","author":"J Holte","year":"1996","journal-title":"Human reproduction (Oxford, England)"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"S Wild","year":"2000","journal-title":"Clinical endocrinology"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"HS Randeva","journal-title":"Endocr Rev"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.2337\/diacare.27.10.2554","article-title":"Gut-derived incretin hormones and new therapeutic approaches","volume":"27","author":"ZT Bloomgarden","year":"2004","journal-title":"Diabetes care"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cen.12468","article-title":"Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome","volume":"81","author":"K Aydin","journal-title":"Clinical endocrinology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"J Vrbikova","year":"2008","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"PF Svendsen","year":"2009","journal-title":"Metabolism: clinical and experimental"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/j.1755-5922.2010.00256.x","article-title":"The cardiovascular effects of GLP-1 receptor agonists","volume":"30","author":"T Okerson","journal-title":"Cardiovascular therapeutics"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"e17178","DOI":"10.1371\/journal.pone.0017178","article-title":"Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy","volume":"6","author":"AK Vyas","journal-title":"PloS one"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"M Jensterle Sever","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"L Manneras","year":"2007","journal-title":"Endocrinology"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1210\/en.2011-1424","article-title":"Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity","volume":"152","author":"J Keller","journal-title":"Endocrinology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.fertnstert.2011.11.015","article-title":"Arteriolar insulin resistance in a rat model of polycystic ovary syndrome","volume":"97","author":"L Sara","journal-title":"Fertility and sterility"},{"key":"ref22","article-title":"Pharmacological reactivity of resistance vessels in a rat PCOS model\u2014vascular effects of parallel vitamin D3 treatment","author":"L Sara","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.genm.2010.11.013","article-title":"Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome","volume":"8","author":"LL Yanes","journal-title":"Gender medicine"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/humrep\/den434","article-title":"Effect of L-dopa on interleukin-1 beta-induced suppression of luteinizing hormone secretion in intact female rats","volume":"24","author":"MP Sirivelu","year":"2009","journal-title":"Human reproduction (Oxford, England)"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/HYPERTENSIONAHA.107.090696","article-title":"Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats","volume":"50","author":"AJ King","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"ref26","first-page":"336","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"UA Ndefo","journal-title":"P T"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"R Azziz","year":"2009","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2011.01.009","article-title":"Ovarian hypertension: polycystic ovary syndrome","volume":"40","author":"R Bentley-Lewis","journal-title":"Endocrinology and metabolism clinics of North America"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000194971","article-title":"Obesity and polycystic ovary syndrome","volume":"2","author":"J Vrbikova","year":"2009","journal-title":"Obesity facts"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/hr.2010.9","article-title":"Mechanisms of obesity-induced hypertension","volume":"33","author":"V Kotsis","journal-title":"Hypertens Res"},{"issue":"1","key":"ref31","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"RS Legro","year":"1999","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1358\/dot.2009.45.2.1336104","article-title":"Liraglutide: a new treatment for type 2 diabetes","volume":"45","author":"T Vilsboll","year":"2009","journal-title":"Drugs Today (Barc)"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/dom.12085","article-title":"Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials","volume":"15","author":"B Wang","journal-title":"Diabetes, obesity & metabolism"},{"issue":"9701","key":"ref34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"A Astrup","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"ref35","first-page":"4382","article-title":"A meta-analysis of the effect of glucagon-like peptide-1 (7\u201336) amide on ad libitum energy intake in humans","volume":"86","author":"C Verdich","year":"2001","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"A Flint","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref37","first-page":"1","article-title":"Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome","volume":"20","author":"M Jensterle","journal-title":"Endocrine research"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the Androgen Excess Society","volume":"92","author":"KE Salley","year":"2007","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11892-014-0564-3","article-title":"PCOS in Adolescence and Type 2 Diabetes","volume":"15","author":"AM Carreau","journal-title":"Current diabetes reports"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/db09-1564","article-title":"Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats","volume":"59","author":"BP Cummings","journal-title":"Diabetes"},{"key":"ref41","first-page":"140","article-title":"The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study","volume":"5","author":"CB Rasmussen","journal-title":"Frontiers in endocrinology"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"A Secher","journal-title":"The Journal of clinical investigation"},{"key":"ref43","unstructured":"DiVasta-AD. PCOS in adolescents: Beyond the reproductive implications. In Contemporary Ob\/Gyn. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/contemporaryobgynmodernmedicinecom\/contemporary-obgyn\/content\/tags\/adolescent-gynecology\/pcos-adolescents-beyond-reproductive-implicati?page=full\" xlink:type=\"simple\">http:\/\/contemporaryobgynmodernmedicinecom\/contemporary-obgyn\/content\/tags\/adolescent-gynecology\/pcos-adolescents-beyond-reproductive-implicati?page=full<\/ext-link> 2013."},{"key":"ref44","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","author":"NM Daan","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1556\/APhysiol.99.2012.3.5","article-title":"Arteriolar biomechanics in a rat polycystic ovary syndrome model\u2014effects of parallel vitamin D3 treatment","volume":"99","author":"L Sara","journal-title":"Acta physiologica Hungarica"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/hh0102.102359","article-title":"Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans","volume":"90","author":"JA Beckman","year":"2002","journal-title":"Circulation research"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","article-title":"Vascular dysfunction and metabolic parameters in polycystic ovary syndrome","volume":"90","author":"C Meyer","year":"2005","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1172\/JCI656","article-title":"Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion","volume":"101","author":"M Morigi","year":"1998","journal-title":"The Journal of clinical investigation"},{"issue":"2 Pt 2","key":"ref49","first-page":"H321","article-title":"Free radicals mediate endothelial cell dysfunction caused by elevated glucose","volume":"263","author":"B Tesfamariam","year":"1992","journal-title":"The American journal of physiology"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcjd.2014.05.001","article-title":"Blood pressure-lowering effects of incretin-based diabetes therapies","volume":"38","author":"JA Lovshin","journal-title":"Canadian journal of diabetes"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"N Lass","journal-title":"The Journal of clinical endocrinology and metabolism"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:56:13Z","timestamp":1540263373000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126119"}},"subtitle":[],"editor":[{"given":"Jaap A.","family":"Joles","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126119","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}